Weiwei Lai

2.3k citations

29 papers · 1.8k · 2 hit papers · h-index 18

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Pulmonary and Respiratory Medicine top 2%
- Ferroptosis and cancer prognosis

Papers in

Molecular Biology 19
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 4
- Circular RNAs in diseases 2
- RNA Research and Splicing 2
Cancer Research 13
- Cancer-related molecular mechanisms research 9
- Cancer, Hypoxia, and Metabolism 2

Co-authors: Yongguang Tao (20 shared papers)Ya Cao (16 shared papers)Desheng Xiao (16 shared papers)Chao Mao (12 shared papers)Yating Liu (11 shared papers)Hu Zhou (7 shared papers)Yiqun Jiang (11 shared papers)Min Wang (6 shared papers)
Journals: Signal Transduction and Targeted Therapy (2 papers)Cell Death and Differentiation (2 papers)Oncogene (2 papers)Oncotarget (2 papers)Cancer Research (2 papers)
Partner nations: China Saudi Arabia United States

In The Last Decade

Weiwei Lai

27 papers receiving 1.8k citations

Weiwei Lai's Hit Papers

align trajectories log scale

Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA 2019 · 435 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cell Death and Differentiation
2018 Cancer Research

Peers

Countries citing papers authored by Weiwei Lai

Since Specialization

Citations

This map shows the geographic impact of Weiwei Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Lai more than expected).

Fields of papers citing papers by Weiwei Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Lai. The network helps show where Weiwei Lai may publish in the future.

Co-authors

The 25 scholars most cited alongside Weiwei Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiwei Lai Line = papers co-authored together Weiwei Lai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA Cell Death and Differentiation ·Min Wang, Chao Mao, Lianlian Ouyang, Yating Liu, Weiwei Lai, Na Liu, Ying Shi, Ling Chen, Desheng Xiao, Fenglei Yu, Xiang Wang, Hu Zhou, Ya Cao, Shuang Liu, Qin Yan, Yongguang Tao, Bin Zhang Hit paper breakdown →	2019	435
2	A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 Cancer Research ·Chao Mao, Xiang Wang, Yating Liu, Min Wang, Bin Yan, Yiqun Jiang, (unknown), Yi Shen, Xiaoli Liu, Weiwei Lai, Rui Yang, Desheng Xiao, Yan Cheng, Shuang Liu, Hu Zhou, Ya Cao, Weishi Yu, Kathrin Muegge, Herbert Yu, Yongguang Tao Hit paper breakdown →	2018	415
3	EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes Theranostics ·Yiqun Jiang, Chao Mao, Rui Yang, Bin Yan, (unknown), Xiaoli Liu, Weiwei Lai, Yating Liu, Xiang Wang, Desheng Xiao, Hu Zhou, Yan Cheng, Fenglei Yu, Ya Cao, Shuang Liu, Qin Yan, Yongguang Tao	2017	244
4	Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase Cancer Research ·Xiaozhen He, Bin Yan, Shuang Liu, Jiantao Jia, Weiwei Lai, Xin Xing, Can‐E Tang, Dixian Luo, Tan Tan, Yiqun Jiang, (unknown), Yating Liu, Desheng Xiao, Ling Chen, Shao Liu, Chao Mao, Gang Yin, (unknown), Jia Fan, Ya Cao, Kathrin Muegge, Yongguang Tao	2016	86
5	Combination of Biochar and Phosphorus Solubilizing Bacteria to Improve the Stable Form of Toxic Metal Minerals and Microbial Abundance in Lead/Cadmium-Contaminated Soil Agronomy ·Weiwei Lai, Yuanyi Wu, Chaonan Zhang, Yimamu Dilinuer, Lhamo Pasang, LU Yu-qi, Yuhong Wang, Haoming Chen, Zhen Li	2022	56
6	PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma Oncogene ·Yating Liu, Lianlian Ouyang, Chao Mao, Yuanbing Chen, Tiansheng Li, Na Liu, Zuli Wang, Weiwei Lai, Yanling Zhou, Ya Cao, Shuang Liu, Yinming Liang, Min Wang, Shouping Liu, Ling Chen, Ying Shi, Desheng Xiao, Yongguang Tao	2022	50
7	Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability Theranostics ·Jiantao Jia, (unknown), Ling Chen, Weiwei Lai, Bin Yan, Yiqun Jiang, Desheng Xiao, Sichuan Xi, Ya Cao, Shuang Liu, Yan Cheng, Yongguang Tao	2017	45
8	LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer Journal of Experimental & Clinical Cancer Research ·Rui Yang, Na Liu, Ling Chen, Yiqun Jiang, (unknown), Chao Mao, Yating Liu, Min Wang, Weiwei Lai, Haosheng Tang, Menghui Gao, Desheng Xiao, Xiang Wang, Fenglei Yu, Ya Cao, Qin Yan, Shuang Liu, Yongguang Tao	2019	43
9	GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3–mediated deubiquitination of LSH Oncogene ·Rui Yang, Na Liu, Ling Chen, Yiqun Jiang, (unknown), Chao Mao, Yating Liu, Min Wang, Weiwei Lai, Haosheng Tang, Menghui Gao, Desheng Xiao, Xiang Wang, Hu Zhou, Can‐E Tang, Wenliang Liu, Fenglei Yu, Ya Cao, Qin Yan, Shuang Liu, Yongguang Tao	2019	42
10	Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells Cancer Letters ·(unknown), Na Liu, Weiwei Lai, Bin Yan, Ling Chen, Shouping Liu, Shuang Liu, Xiang Wang, Desheng Xiao, Xiaoli Liu, Chao Mao, Yiqun Jiang, Jiantao Jia, Yating Liu, Rui Yang, Ya Cao, Yongguang Tao	2018	39
11	Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing Oncotarget ·Weiwei Lai, Jiantao Jia, Bin Yan, Yiqun Jiang, (unknown), Ling Chen, Chao Mao, Xiaoli Liu, Haosheng Tang, Menghui Gao, Ya Cao, Shuang Liu, Yongguang Tao	2017	34
12	As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Shuang Liu, Bin Yan, Weiwei Lai, Ling Chen, Desheng Xiao, Sichuan Xi, Yiqun Jiang, Xin Dong, Jing An, Xiang Chen, Ya Cao, Yongguang Tao	2014	33
13	GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer Signal Transduction and Targeted Therapy ·Yao Long, Jiaxing Guo, Jielin Chen, Jingyue Sun, Haiyan Wang, Xin Peng, Zuli Wang, Weiwei Lai, Na Liu, Long Shu, Ling Chen, Ying Shi, Desheng Xiao, Shuang Liu, Yongguang Tao	2023	32
14	AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function Journal of Cancer ·Yuanhao Peng, Lianlian Ouyang, Yangying Zhou, Weiwei Lai, Yuanbing Chen, Zuli Wang, Bokang Yan, Zewen Zhang, Yanling Zhou, Xintong Peng, Jielin Chen, Xin Peng, Desheng Xiao, Shuang Liu, Yongguang Tao, Wenliang Liu	2023	28
15	Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA Cell Death and Differentiation ·Min Wang, Chao Mao, Lianlian Ouyang, Yating Liu, Weiwei Lai, Na Liu, Ying Shi, Ling Chen, Desheng Xiao, Fenglei Yu, Xiang Wang, Hu Zhou, Ya Cao, Shuang Liu, Qin Yan, Yongguang Tao, Bin Zhang	2019	28
16	The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties Signal Transduction and Targeted Therapy ·Na Liu, Rui Yang, (unknown), Ling Chen, Yating Liu, Zuli Wang, Shouping Liu, Lianlian Ouyang, Haiyan Wang, Weiwei Lai, Chao Mao, Min Wang, Yan Cheng, Shuang Liu, Xiang Wang, Hu Zhou, Ya Cao, Desheng Xiao, Yongguang Tao	2020	25
17	LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway Oncotarget ·Jiantao Jia, (unknown), Bin Yan, Deshen Xiao, Weiwei Lai, Yu Pan, Yiqun Jiang, Ling Chen, Chao Mao, Jian Zhou, Sichuan Xi, Ya Cao, Shuang Liu, Yongguang Tao	2016	24
18	DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism Epigenetics & Chromatin ·Ling Chen, Ying Shi, Na Liu, Zuli Wang, Rui Yang, Bin Yan, Xiaoli Liu, Weiwei Lai, Yating Liu, Desheng Xiao, Hu Zhou, Yan Cheng, Ya Cao, Shuang Liu, Zanxian Xia, Yongguang Tao	2019	22
19	Antitumor activity of Polygonatum sibiricum polysaccharides Archives of Pharmacal Research ·Weiwei Lai, Qian Ning, Guihua Wang, Yuan Gao, Shuxian Liao, Shengsong Tang	2024	17
20	Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers npj Precision Oncology ·Shouping Liu, Weiwei Lai, Ying Shi, Na Liu, Lianlian Ouyang, Ziying Zhang, Ling Chen, Xiang Wang, Banglun Qian, Desheng Xiao, Qin Yan, Ya Cao, Shuang Liu, Yongguang Tao	2020	14

About Weiwei Lai

Weiwei Lai is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (9 papers), Epigenetics and DNA Methylation (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related gene regulation (4 papers), Circular RNAs in diseases (2 papers), RNA Research and Splicing (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (976 citations), Pulmonary and Respiratory Medicine (853 citations), Molecular Biology (1.2k citations), Oncology (122 citations) and Immunology (62 citations). Weiwei Lai has collaborated with scholars based in China, Saudi Arabia and United States. Frequent co-authors include Yongguang Tao, Ya Cao, Desheng Xiao, Chao Mao, Yating Liu, Hu Zhou, Yiqun Jiang, Min Wang, Bin Yan and Shuang Liu. Their work appears in journals such as Signal Transduction and Targeted Therapy, Cell Death and Differentiation, Oncogene, Oncotarget and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Weiwei Lai

Impact in

Papers in i

In The Last Decade

Weiwei Lai

Weiwei Lai's Hit Papers

Peers

Countries citing papers authored by Weiwei Lai

Fields of papers citing papers by Weiwei Lai

All Works

About Weiwei Lai

Explore authors with similar magnitude of impact

Papers in